PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch
TORONTO and ANDERNACH, Germany, Dec. 20, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the development and commercialization of ...
Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results